Full year report 2021 (January-December 2021)
2022-02-10 @ 08:00
Report will be released at 8.00am CET and conference call at 10.00am CET
About us
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway.
Headquarter is in Malmö, Sweden, and the company’s shares are listed on Nasdaq Stockholm (ticker: ACE)
Download our fact sheet: Ascelia Pharma Factsheet Dec 2020
Latest news
- 2021-04-09Issue and repurchase of series C shares for share saving program
- 2021-03-31NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
- 2021-03-31Number of shares and votes in Ascelia Pharma AB
- 2021-03-30Ascelia Pharma publishes Annual Report for 2020
- 2021-03-17Notice of extraordinary general meeting in Ascelia Pharma
Events
- April 28 @ 11:15 - 11:35
Redeye Orphan Drugs Seminar – April 2021
- May 5 @ 14:00 - 16:00
Annual General Meeting 2021
- May 12 @ 08:00
Interim Report Q1 2021 (January-March 2021)
- May 25
ABGSC Life Science Summit
- August 19 @ 08:00
Half-year report 2021 (April-June 2021)